Changing global policy to deliver safe, equitable, and affordable care for women's cancers

The Lancet

Volumn 389, Issue 10071, 2017, Pages 871-880

  Ginsburg, Ophira ^a,b   Badwe, Rajan ^c   Boyle, Peter ^d,e   Derricks, Gemma ^f   Dare, Anna ^g   Evans, Tim ^h   Eniu, Alexandru ⁱ   Jimenez, Jorge ^j   Kutluk, Tezer ^k   Lopes, Gilberto ^l,m   Mohammed, Sulma I ^n,o   Qiao, You Lin ^p   Rashid, Sabina Faiz ^q   Summers, Diane ^r   Sarfati, Diana ^s   Temmerman, Marleen ^b,t,u   Trimble, Edward L ^v   Padela, Aasim I ^w   Aggarwal, Ajay ^x,y   Sullivan, Richard ^y  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c TATA MEMORIAL HOSPITAL   (India)

^d INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^e UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^f BRUNEL UNIVERSITY   (United Kingdom)

^g UNIVERSITY OF TORONTO   (Canada)

^h WORLD BANK GROUP   (United States)

ⁱ Cancer Institute Ion Chiricuta Cluj Napoca   (Romania)

^j PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^k HACETTEPE UNIVERSITY   (Turkey)

^l Oncoclinicas Institute   (Brazil)

^m UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁿ Purdue University   (United States)

^o INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p PEKING UNION MEDICAL COLLEGE   (China)

^q BRAC UNIVERSITY   (Bangladesh)

^r UNICEF   (United States)

^s UNIVERSITY OF OTAGO   (New Zealand)

^t GHENT UNIVERSITY   (Belgium)

^u AGA KHAN UNIVERSITY   (Pakistan)

^v NATIONAL CANCER INSTITUTE   (United States)

^w UNIVERSITY OF CHICAGO   (United States)

^x LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^y KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CONTROL; CLINICAL RESEARCH; COST OF ILLNESS; EVIDENCE BASED PRACTICE; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE FINANCING; HEALTH CARE POLICY; HEALTH EQUITY; HEALTH INSURANCE; HUMAN; INTELLIGENCE; INVESTMENT; MALIGNANT NEOPLASM; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; WOMEN'S HEALTH; DEVELOPING COUNTRY; GLOBAL HEALTH; MANAGEMENT; PUBLIC POLICY; SOCIOECONOMICS; WOMEN'S RIGHTS;

DEVELOPING COUNTRIES; FEMALE; GLOBAL HEALTH; HUMANS; POLICY MAKING; PUBLIC POLICY; SOCIOECONOMIC FACTORS; WOMEN'S HEALTH; WOMEN'S RIGHTS;

EID: 85005767593     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)31393-9     Document Type: Review

References (74)

1. 1 Langer, A, Meleis, A, Knaul, FM, et al. Women and health: the key for sustainable development. Lancet 386 (2015), 1165–1210.
2. 2 Kim, JY, Farmer, P, Porter, ME, Redefining global health-care delivery. Lancet 382 (2013), 1060–1109.
3. 3 Venkatapuram, S, Marmot, M, Epidemiology and social justice in light of social determinants of health research. Bioethics 23 (2009), 79–89.
4. 4 Roberts, I, Jackson, R, Beyond disease burden: towards solution-oriented population health. Lancet 381 (2013), 2219–2221.
5. 5 Ginsburg, O, Bray, F, Coleman, MP, et al. The global burden of women's cancers: a grand challenge in global health. Lancet, 2016 published online Nov 1. http://dx.doi.org/10.1016/S0140-6736(16)31392-7.
6. 6 Denny, L, de Sanjose, S, Mutebi, M, et al. Interventions to close the divide for women with cancer in low-income, middle-income, and high-income countries. Lancet, 2016 published online Nov 1. http://dx.doi.org/10.1016/S0140-6736(16)31795-0.
7. 7 Mathers, CD, Loncar, D, Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med, 3, 2006, e442.
8. 8 AbouZahr, C, de Savigny, D, Mikkelsen, L, et al. Civil registration and vital statistics: progress in the data revolution for counting and accountability. Lancet 386 (2015), 1373–1385.
9. 9 Mathers, CD, Ma Fat, D, Inoue, M, Rao, C, Lopez, AD, Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ 83 (2005), 171–217.
10. 10 Meara, JG, Leather, AJ, Hagander, L, et al. Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet 386 (2015), 569–624.
11. 11 Sullivan, R, Alatise, OI, Anderson, BO, et al. Global cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncol 16 (2015), 1193–1224.
12. 12 Atun, R, Jaffray, DA, Barton, MB, et al. Expanding global access to radiotherapy. Lancet Oncol 16 (2015), 1153–1186.
13. 13 Wollum, A, Burstein, R, Fullman, N, Dwyer-Lindgren, L, Gakidou, E, Benchmarking health system performance across states in Nigeria: a systematic analysis of levels and trends in key maternal and child health interventions and outcomes, 2000–2013. BMC Med, 13, 2015, 208.
14. 14 Weiss, CH, The many meanings of research utilization. Public Adm Rev 39 (1979), 426–431.
15. 15 Kingdon, JW, Thurber, JA, Agendas, alternatives, and public policies, 1984, Little Brown, Boston.
16. 16 Haynes, AS, Gillespie, JA, Derrick, GE, et al. Galvanizers, guides, champions, and shields: the many ways that policymakers use public health researchers. Millbank Q 89 (2011), 564–598.
17. 17 Percy-Smith, J, Burden, T, Darlow, A, Dowson, L, Hawtin, M, Ladi, S, Promoting change through research: The impact of research in local government. 2002. https://http://www.jrf.org.uk/report/promoting-change-through-research-impact-research-local-government (accessed Dec 4, 2015).
18. 18 Feldman, PH, Nadash, P, Gursen, M, Improving communication between researchers and policy makers in long-term care: or, researchers are from Mars; policy makers are from Venus. Gerontologist 41 (2001), 312–321.
19. 19 Research Exercise Framework. Panel criteria and working methods. http://www.ref.ac.uk/pubs/2012-01/, 2014 (accessed Jan 2, 2016).
20. 20 Raffle, AE, Challenges of implementing human papillomavirus (HPV) vaccination policy. BMJ 335 (2007), 375–377.
21. 21 Rottingen, JA, Regmi, S, Eide, M, et al. Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?. Lancet 382 (2013), 1286–1307.
22. 22 Venkatapuram, S, Health, vital goals, and central human capabilities. Bioethics 27 (2013), 271–279.
23. 23 Balarajan, Y, Selvaraj, S, Subramanian, SV, Health care and equity in India. Lancet 377 (2011), 505–515.
24. 24 Glassman, A, Chalkidou, K, Priority-setting in health. Building institutions for smarter public spending, 2012, Centre for Global Development, Washington, DC.
25. 25 Beaglehole, R, Bonita, R, Alleyne, G, et al. UN High-Level Meeting on Non-Communicable Diseases: addressing four questions. Lancet 378 (2011), 449–455.
26. 26 Pramesh, CS, Badwe, RA, Borthakur, BB, et al. Delivery of affordable and equitable cancer care in India. Lancet Oncol 15 (2014), e223–e233.
27. 27 Stulac, S, Binagwaho, A, Tapela, NM, et al. Capacity building for oncology programmes in sub-Saharan Africa: the Rwanda experience. Lancet Oncol 16 (2015), e405–e413.
28. 28 Balabanova, D, Mills, A, Conteh, L, et al. Good Health at Low Cost 25 years on: lessons for the future of health systems strengthening. Lancet 381 (2013), 2118–2133.
29. 29 United Nations: gender equality and women's empowerment. http://www.un.org/sustainabledevelopment/gender-equality/ (accessed Sept 23, 2016).
30. 30 US Health in International Perspective. Shorter Lives, Poorer Lives, 2013, Panel on Understanding Cross-National Health Differences Among High-Income Countries, Committee on Population, Division of Behavioral and Social Sciences and Education, and Board on Population Health and Public Health Practice, Institute of Medicine, Washington, DC.
31. 31 Gelband, H, Sankaranarayanan, R, Gauvreau, C, et al. The costs, affordability and feasibility of an essential package of cancer control interventions in low- and middle-income countries. Lancet 387 (2015), 2133–2144.
32. 32 Anderson, BO, Cazap, E, El Saghir, NS, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol 12 (2011), 387–398.
33. 33 Jamison, DT, Summers, LH, Alleyne, G, et al. Global health 2035: a world converging within a generation. Lancet 382 (2013), 1898–1955.
34. 34 Kimman, M, Jan, S, Yip, CH, et al., for the ACTION Study Group. Catastrophic health expenditure and 12-month mortality associated with cancer in Southeast Asia: results from a longitudinal study in eight countries. BMC Med, 13, 2015, 190.
35. 35 Hamid, SA, Ahsan, SM, Begum, A, Disease-specific impoverishment impact of out-of-pocket payments for health care: evidence from rural Bangladesh. Appl Health Econ Health Pol 12 (2014), 421–433.
36. 36 Sachs, JD, Achieving universal health coverage in low-income settings. Lancet 380 (2012), 944–947.
37. 37 Lagomarsino, G, Garabrant, A, Adyas, A, Muga, R, Otoo, N, Moving towards universal health coverage: health insurance reforms in nine developing countries in Africa and Asia. Lancet 380 (2012), 933–943.
38. 38 What happened to personalized medicine?. Nat Biotechnol, 30, 2012, 1.
39. 39 Quick, J, Jay, J, Langer, A, Improving women's health through universal health coverage. PLoS Med, 11, 2014, e1001580.
40. 40 Knaul, FM, Gonzalez-Pier, E, Gomez-Dantes, O, et al. The quest for universal health coverage: achieving social protection for all in Mexico. Lancet 380 (2012), 1259–1279.
41. 41 Mohar, A, Bargallo, E, Ramirez, MT, Lara, F, Beltran-Ortega, A, Available resources for the treatment of breast cancer in Mexico. Salud Publica Mex 51:suppl 2 (2009), s263–s269.
42. 42 Frenk, J, Gomez-Dantes, O, Langer, A, A comprehensive approach to women's health: lessons from the Mexican health reform. BMC Womens Health, 12, 2012, 42.
43. 43 Arce-Salinas, C, Lara-Medina, FU, Alvarado-Miranda, A, et al. Evaluation of breast cancer treatment at a tertiary-level institution with Popular Health Insurance in Mexico. Rev Invest Clin 64 (2012), 9–16.
44. 44 Chalkidou, K, Marquez, P, Dhillon, PK, et al. Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries. Lancet Oncol 15 (2014), e119–e131.
45. 45 Youngkong, S, Baltussen, R, Tantivess, S, Mohara, A, Teerawattananon, Y, Multicriteria decision analysis for including health interventions in the universal health coverage benefit package in Thailand. Value Health 15 (2012), 961–970.
46. 46 Puri, L, Transformative financing for gender equality and women's empowerment:catalysing action on the Addis Ababa Accord. Speech by UN Women Deputy Executive Director, 2015, UN Women, July 14, Addis Ababa, Ethiopia.
47. 47 Goss, PE, Strasser-Weippl, K, Lee-Bychkovsky, BL, et al. Challenges to effective cancer control in China, India, and Russia. Lancet Oncol 15 (2014), 489–538.
48. 48 Dikshit, R, Gupta, PC, Ramasundarahettige, C, et al. Cancer mortality in India: a nationally representative survey. Lancet 379 (2012), 1807–1816.
49. 49 eCancer. National Cancer Grid for India. eCancerTV: Open Access. http://ecancer.org/video/2522/national-cancer-grid-for-india.php, 2013 (accessed Feb 4, 2016).
50. 50 Mallath, MK, Taylor, DG, Badwe, RA, et al. The growing burden of cancer in India: epidemiology and social context. Lancet Oncol 15 (2014), e205–e212.
51. 51 Dieleman, JL, Graves, CM, Templin, T, et al. Global health development assistance remained steady in 2013 but did not align with recipients’ disease burden. Health Aff 33 (2014), 878–886.
52. 52 Alkire, BC, Shrime, MG, Dare, AJ, Vincent, JR, Meara, JG, Global economic consequences of selected surgical diseases: a modelling study. Lancet Glob Health 3:suppl 2 (2015), S21–S27.
53. 53 UN. Every Women Every Child: Global strategy for women's and children's health, 2010, United Nations, Geneva, Switzerland.
54. 54 Stenberg, K, Axelson, H, Sheehan, P, et al. Advancing social and economic development by investing in women's and children's health: a new Global Investment Framework. Lancet 383 (2014), 1441–1443.
55. 55 Addis Ababa Action Plan. Global Financing Facility. http://www.worldbank.org/en/news/press-release/2015/07/13/global-financing-facility-launched-with-billions-already-mobilized-to-end-maternal-and-child-mortality-by-2030 (accessed Sept 19, 2016).
56. 56 Sullivan, R, Peppercorn, J, Sikora, K, et al. Delivering affordable cancer care in high-income countries. Lancet Oncol 12 (2011), 933–980.
57. 57 Bhutta, ZA, Chopra, M, Axelson, H, et al. Countdown to 2015 decade report (2000–10): taking stock of maternal, newborn, and child survival. Lancet 375 (2010), 2032–2044.
58. 58 Herrera Riquelme, CA, Kuhn-Barrientos, L, Rosso Astorga, R, Jiménez de la Jara, J, Trends in mortality from cancer in Chile according to differences in educational level, 2000–2010. Revista Panam Salud Pública 37 (2015), 44–51.
59. 59 USAID. Using evidence to design health benefit plans for stronger health systems: lessons from 25 countries, 2015, USAID, Washington, DC.
60. 60 Autier, P, Boniol, M, Middleton, R, et al. Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol 22 (2011), 1726–1735.
61. 61 Kidd, AD, Colbert, AM, Jatoi, I, Mammography: review of the controversy, health disparities, and impact on young african american women. Clin J Oncol Nurs 19 (2015), E52–E58.
62. 62 Padela, AI, Curlin, FA, Religion and disparities: considering the influences of Islam on the health of American Muslims. J Relig Health 52 (2013), 1333–1345.
63. 63 Shaheen, M, Galal, O, Practices for early detection of breast cancer among Muslim women in Southern California. Ann Epidemiol, 15, 2005, 649.
64. 64 Hasnain, M, Menon, U, Ferrans, CE, Szalacha, L, Breast cancer screening practices among first-generation immigrant muslim women. J Womens Health 23 (2014), 602–612.
65. 65 Padela, AI, Murrar, S, Adviento, B, et al. Associations between religion-related factors and breast cancer screening among American Muslims. J Immigr Minor Health 17 (2015), 660–669.
66. 66 Sancho-Garnier, H, Khazraji, YC, Cherif, MH, et al. Overview of cervical cancer screening practices in the extended Middle East and North Africa countries. Vaccine 31:suppl 6 (2013), G51–G57.
67. 67 Wigle, J, Coast, E, Watson-Jones, D, Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): health system experiences and prospects. Vaccine 31 (2013), 3811–3817.
68. 68 Strother, RM, Asirwa, FC, Busakhala, NB, et al. AMPATH-Oncology: a model for comprehensive cancer care in sub-Saharan Africa. J Cancer Policy 1 (2013), e42–e48.
69. 69 Plummer, M, de Martel, C, Vignat, J, et al. Global burden of cancers attributable to infections in 2012. Lancet Glob Health 4 (2016), e609–e616.
70. 70 Chang, MH, You, SL, Chen, CJ, et al. Decreased incidence of hepatocellular carcinoma in hepatitis b vaccines: a 20-year follow-up study. J Natl Cancer Inst 101 (2009), 1348–1355.
71. 71 Canfell, K, Chesson, H, Kulasingam, SL, Berkhof, J, Diaz, M, Kim, JJ, Modeling preventative strategies against human papillomavirus-related disease in developed countries. Vaccine 30:suppl 5 (2012), F157–F167.
72. 72 WHO. Comprehensive Cervical Cancer Control: a guide to essential practice, 2nd edition, 2014, World Health Organization, Geneva, Switzerland.
73. 73 WHO. WHO position paper on mammography screening, 2014, World Health Organization, Geneva, Switzerland http://www.who.int/cancer/publications/mammography_screening/en/ (accessed Nov 3, 2015).
74. 74 GAVI, the Vaccine Alliance. The 2016–2020 Investment Opportunity. http://www.gavi.org/replenishment-launch/investment-opportunity/ (accessed Dec 10, 2015).